Literature DB >> 24859635

Significant associations between lipoprotein(a) and corrected apolipoprotein B-100 levels in African-Americans.

Byambaa Enkhmaa1, Erdembileg Anuurad1, Wei Zhang1, Lars Berglund2.   

Abstract

OBJECTIVES: Lipoprotein(a), Lp(a), represents an apolipoprotein (apo) B-carrying lipoprotein, yet the relationship between Lp(a) and apoB levels has not been fully explored.
METHODS: We addressed the relationship between Lp(a) and apoB-containing lipoprotein levels in 336 Caucasians and 224 African-Americans. Our approach takes unique molecular properties of Lp(a) as well as contribution of Lp(a) to the levels of these lipoproteins into account.
RESULTS: Levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apoB and apoB/apoA-1 did not differ across ethnicity. African-Americans had higher levels of Lp(a) and high-density lipoprotein cholesterol and lower triglyceride levels compared to Caucasians. Lp(a) levels were correlated with levels of TC (p < 0.005), LDL-C (p < 0.001), apoB (p < 0.05) or apoB/apoA-1 (p < 0.05) in both ethnic groups. These associations remained significant only in African-Americans after adjustments for the contribution of Lp(a)-cholesterol or Lp(a)-apoB. Furthermore, taking Lp(a)-apoB into account, allele-specific apo(a) levels were significantly associated with apoB levels and the apoB/apoA-1 ratio in African-Americans. The latter associations in African-Americans remained significant for allele-specific apo(a) levels for smaller apo(a) sizes (<26 K4 repeats), after controlling for the effects of age, sex, and BMI.
CONCLUSIONS: Although TC, LDL-C, and apoB levels were comparable between African-Americans and Caucasians, the associations of these parameters with Lp(a) and allele specific apo(a) levels differed between these two ethnic groups. In African-Americans, apoB and apoB/apoA-1 remained consistently and positively associated with both Lp(a) and allele-specific apo(a) levels after adjustments for the contribution of Lp(a)-apoB. The findings suggest an interethnic difference with a closer relationship between Lp(a) and apoB among African-Americans.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Apo(a) sizes; Corrections for the contribution of Lp(a); Ethnicity; K4 repeats; Plasma lipids

Mesh:

Substances:

Year:  2014        PMID: 24859635      PMCID: PMC4095745          DOI: 10.1016/j.atherosclerosis.2014.04.035

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  50 in total

1.  Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians.

Authors:  Jill Rubin; Furcy Paultre; Catherine H Tuck; Steve Holleran; Roberta G Reed; Thomas A Pearson; Christopher M Thomas; Rajasekhar Ramakrishnan; Lars Berglund
Journal:  J Lipid Res       Date:  2002-02       Impact factor: 5.922

2.  Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNA.

Authors:  M L Koschinsky; U Beisiegel; D Henne-Bruns; D L Eaton; R M Lawn
Journal:  Biochemistry       Date:  1990-01-23       Impact factor: 3.162

3.  The metabolism of lipoprotein(a) and other apolipoprotein B-containing lipoproteins: a kinetic study in humans.

Authors:  T Demant; K Seeberg; A Bedynek; D Seidel
Journal:  Atherosclerosis       Date:  2001-08       Impact factor: 5.162

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  Differential influence of LDL cholesterol and triglycerides on lipoprotein(a) concentrations in diabetic patients.

Authors:  C Hernández; P Chacón; L García-Pascual; R Simó
Journal:  Diabetes Care       Date:  2001-02       Impact factor: 19.112

6.  Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid.

Authors:  L A Carlson; A Hamsten; A Asplund
Journal:  J Intern Med       Date:  1989-10       Impact factor: 8.989

7.  HIV disease activity as a modulator of lipoprotein(a) and allele-specific apolipoprotein(a) levels.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Wei Zhang; Adnan Abbuthalha; Xiao-Dong Li; William Dotterweich; Richard B Pollard; David M Asmuth; Lars Berglund
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11-29       Impact factor: 8.311

8.  Black-white differences in serum Lp(a) lipoprotein levels.

Authors:  H J Parra; I Luyéyé; C Bouramoué; C Demarquilly; J C Fruchart
Journal:  Clin Chim Acta       Date:  1987-09-15       Impact factor: 3.786

9.  ApoA- and apoB-containing lipoproteins and Lp(a) concentration in non-dialyzed patients with chronic renal failure.

Authors:  Elibieta Kimak; Janusz Solski
Journal:  Ren Fail       Date:  2002-07       Impact factor: 2.606

10.  Isolation and partial characterization of apolipoprotein (a) from human lipoprotein (a).

Authors:  L J Seman; W C Breckenridge
Journal:  Biochem Cell Biol       Date:  1986-10       Impact factor: 3.626

View more
  6 in total

1.  The roles of apo(a) size, phenotype, and dominance pattern in PCSK9-inhibition-induced reduction in Lp(a) with alirocumab.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Wei Zhang; Kun Yue; Ching-Shang Li; Lars Berglund
Journal:  J Lipid Res       Date:  2017-08-10       Impact factor: 5.922

2.  Effect of antiretroviral therapy on allele-associated Lp(a) level in women with HIV in the Women's Interagency HIV Study.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Wei Zhang; Chin-Shang Li; Robert Kaplan; Jason Lazar; Dan Merenstein; Roksana Karim; Brad Aouizerat; Mardge Cohen; Kenneth Butler; Savita Pahwa; Igho Ofotokun; Adaora A Adimora; Elizabeth Golub; Lars Berglund
Journal:  J Lipid Res       Date:  2018-07-16       Impact factor: 5.922

Review 3.  Diet and Lp(a): Does Dietary Change Modify Residual Cardiovascular Risk Conferred by Lp(a)?

Authors:  Byambaa Enkhmaa; Kristina S Petersen; Penny M Kris-Etherton; Lars Berglund
Journal:  Nutrients       Date:  2020-07-07       Impact factor: 5.717

4.  Is the ratio of apoB/apoA-1 the best predictor for the severity of coronary artery lesions in Chinese diabetics with stable angina pectoris? An assessment based on Gensini scores.

Authors:  Li-Feng Hong; Xiao-Ni Yan; Ying Fan; Qiong Wu; Song-Hui Luo; Bo Yang; Jian-Jun Li
Journal:  J Geriatr Cardiol       Date:  2015-07       Impact factor: 3.327

5.  Lipoprotein(a) and the Apolipoprotein B/A1 Ratio Independently Associate With Surgery for Aortic Stenosis Only in Patients With Concomitant Coronary Artery Disease.

Authors:  Johan Ljungberg; Anders Holmgren; Ingvar A Bergdahl; Johan Hultdin; Margareta Norberg; Ulf Näslund; Bengt Johansson; Stefan Söderberg
Journal:  J Am Heart Assoc       Date:  2017-12-15       Impact factor: 5.501

Review 6.  Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics.

Authors:  Daniel I Swerdlow; David A Rider; Arash Yavari; Marie Wikström Lindholm; Giles V Campion; Steven E Nissen
Journal:  Cardiovasc Res       Date:  2022-03-25       Impact factor: 10.787

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.